Panel Discussion | Who Should Get Embolic Protection Device During TAVR?

Monday, March 9, 2026

2:10 PM - 2:25 PM EST

Location: Cabinet

Moderator(s)

Michael G. Dwyer, PhD

Associate Professor of Neurology and Biomedical Informatics
University at Buffalo
Buffalo, New York, United States

Disclosure(s): Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure information not submitted.

Panel Discussant(s)

Neel Butala, MD

Medical Director of Structural Heart Disease and Intervention
Rocky Mountain Regional VA Medical Center

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)
Abhishek Chaturvedi, MD

Interventional Cardiologist & Assistant Professor of Medicine
West Virginia University Heart & Vascular Institute, United States

Disclosure(s): No financial relationships to disclose
David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Michael G. Dwyer, PhD: Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Neel Butala, MD: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)

Abhishek Chaturvedi, MD: No financial relationships to disclose

David J. Cohen, MD, FSCAI: Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)